Genetic testing and prognosis of sarcomatoid hepatocellular carcinoma patients.

Front Oncol · 2022 · PMC9891294 · PMID 36741696

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

SHCs with FAT1 or EGFR mutations showed a trend toward higher TMB, but there was no significant difference between the wild-type and mutated groups ( Figure 3 ). 3.4 Prognostic predictors of SHC We obtained the survival data of 20 patients during the follow-up, 17 patients died and 3 survived by the end of follow-up.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.